IL-6 antagonists may be associated with lower mortality in adults hospitalized with COVID-19
Question Are interleukin-6 antagonists effective in decreasing mortality among persons hospitalized with COVID-19? Conclusion Based on this systematic review, it is unclear if IL-6 antagonists decrease mortality among persons hospitalized with COVID-19. Co-intervention with corticosteroids has muddied the waters, and…